⌘K

Login Start Free

Home/Filings/4/0001209191-18-030725

4//SEC Filing

Soffer Gad 4

Accession 0001209191-18-030725

CIK 0001604464other

View on SEC.gov Company Profile

Filed

May 15, 8:00 PM ET

Accepted

May 16, 8:39 PM ET

Size

4.9 KB

Accession

0001209191-18-030725

Insider Transaction Report

Form 4

Period: 2018-05-15

Atara Biotherapeutics, Inc.ATRA

Chief Operating Officer

Transactions

Tax Payment
Common Stock
2018-05-15$45.90/sh−382$17,534→ 266,506 total

Footnotes (1)

[F1]Shares withheld to cover tax obligation from settlement of vested restricted stock units.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Atara Biotherapeutics, Inc.

CIK 0001604464

Entity typeother

Related Parties

1

filerCIK 0001612090

Filing Metadata

Form type: 4
Filed: May 15, 8:00 PM ET
Accepted: May 16, 8:39 PM ET
Size: 4.9 KB

View on SEC.gov